Survival data in elderly patients with locally advanced non-small cell lung cancer

被引:12
作者
Domingues, Pedro Masson [1 ,2 ]
Zylberberg, Ricardo [1 ,2 ]
de Castro, Thalita da Matta [3 ]
Baldotto, Clarissa Serodio [1 ,2 ]
de Lima Araujo, Luiz Henrique [1 ,2 ]
机构
[1] Inst Nacl Canc INCA, Dept Med Oncol, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc INCA, Thorac Oncol Tumor Grp, BR-20230130 Rio De Janeiro, RJ, Brazil
[3] Inst Nacl Canc INCA, BR-20230130 Rio De Janeiro, RJ, Brazil
关键词
Lung neoplasms; Elderly; Chemoradiotherapy; Survival;
D O I
10.1007/s12032-012-0449-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Combined chemoradiation (CRT) is the standard therapy in locally advanced non-small cell lung cancer (NSCLC). Nevertheless, the best approach in the elderly population is still poorly defined. We retrospectively reviewed the charts of elderly (>= 65 years) patients with unresectable, locally advanced NSCLC, diagnosed at the Brazilian National Cancer Institute between 2003 and 2007. The primary outcome was overall survival (OS), measured from diagnosis until death. Palliative therapy (PT) included best supportive care radiation therapy (RT; <= 40 Gy) and palliative chemotherapy. Among patients treated with radical RT, OS was measured from date of treatment beginning until death (OST). One hundred seventy-one patients were included, with median age of 71 years (range 65-90). Thirty-nine percent received PT, 32 % exclusive RT (>40 Gy), and 29 % CRT (concomitant or sequential). Patients treated with RT and CRT had better OS (median 13.7 months [95 % CI 10.9-16.4] and 15.5 months [95 % CI 13.0-17.9]) than PT (median 4.1 months [95 % CI 3.6-4.6]; p < 0.0001). In the multivariate analysis, RT (HR 0.28 [95 % CI 0.18-0.42]; p < 0.0001) and CRT (HR 0.17 [95 % CI 0.1-0.27]; p < 0.0001) were independently correlated to better survival in comparison with PT. Among patients receiving radical RT, the addition of chemotherapy was correlated to longer OST (median 13.8 [95 % CI 10.6-17.0] vs. 10.8 months [95 % CI 8.6-13.1]; p = 0.018). This benefit was confirmed in the multivariate analysis (HR 0.59 [95 % CI 0.36-0.97]; p = 0.039). Elderly patients with locally advanced NSCLC derived significant survival benefit from radical RT and CRT, suggesting that age should not be a contraindication for these aggressive therapeutic strategies.
引用
收藏
页数:6
相关论文
共 14 条
[1]  
[Anonymous], 2002, Statistical Models and Methods for Lifetime Data
[2]   Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC):: A meta-analysis of individual data from 1764 patients [J].
Aupérin, A ;
Le Péchoux, C ;
Pignon, JP ;
Koning, C ;
Jeremic, B ;
Clamon, G ;
Einhorn, L ;
Ball, D ;
Trovo, MG ;
Groen, HJM ;
Bonner, JA ;
Le Chevalier, T ;
Arriagada, R .
ANNALS OF ONCOLOGY, 2006, 17 (03) :473-483
[3]   Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].
Auperin, Anne ;
Le Pechoux, Cecile ;
Rolland, Estelle ;
Curran, Walter J. ;
Furuse, Kiyoyuki ;
Fournel, Pierre ;
Belderbos, Jose ;
Clamon, Gerald ;
Ulutin, Hakki Cuneyt ;
Paulus, Rebecca ;
Yamanaka, Takeharu ;
Bozonnat, Marie-Cecile ;
Uitterhoeve, Apollonia ;
Wang, Xiaofei ;
Stewart, Lesley ;
Arriagada, Rodrigo ;
Burdett, Sarah ;
Pignon, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190
[4]  
Cavalcanti L, 2012, J CLIN ONCOL, V30
[5]   Treatment of the Elderly When Cure is the Goal The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer [J].
Coate, Linda E. ;
Massey, Christine ;
Hope, Andrew ;
Sacher, Adrian ;
Barrett, Katherine ;
Pierre, Andrew ;
Leighl, Natasha ;
Brade, Anthony ;
de Perrot, Marc ;
Waddell, Tom ;
Liu, Geoffrey ;
Feld, Ronald ;
Burkes, Ronald ;
Cho, B. C. John ;
Darling, Gail ;
Sun, Alexander ;
Keshavjee, Shaf ;
Bezjak, Andrea ;
Shepherd, Frances A. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :537-544
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer [J].
Davidoff, Amy J. ;
Gardner, James F. ;
Seal, Brian ;
Edelman, Martin J. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) :934-941
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]  
Langer CJ, 2002, P AN M AM SOC CLIN, V21, p75s
[10]  
Okamoto H, 2012, J CLIN ONCOL S, V30